Abbott Laboratories



‡ Abbott Laboratories (NYSE: ABT) is a pharmaceutical health care company. ‡ It has 72,000 employees and operates in over 130 countries. ‡ The company headquarters are in Abbott Park, North Chicago, Illinois. ‡ The company was founded by Chicago physician, Dr. Wallace Calvin Abbott in 1888. ‡ In 1985, the company developed the first HIV blood screening test. ‡ In 2008, Abbott had over $29 billion in revenue.

‡ Abbott's core businesses focus on pharmaceuticals, medical devices and nutritional products, which have been supplemented through several notable acquisitions. The firm currently divides itself into several divisions: ‡ Animal Health: Anesthesia for animals, Clinicare liquid animal diets and other veterinary products. ‡ Diabetes Care: Glucose monitoring device and medicine.

Business Cont«
‡ Diagnostics: Hematology, immunodiagnostic, oncology and clinical chemistry (including the i-Stat). ‡ Molecular: analysis of DNA, RNA, and proteins at the molecular level. ‡ Nutrition: Baby Nutrition (Similac, Isomil, and Gain), adult health products (Ensure and ZonePerfect) and special dietary needs (Glucerna). ‡ Vascular: Stents, vessel closure devices, endovascular and coronary technologies.

‡ 2010 has been a year of celebration for Abbott Pakistan as we achieved our vision of Rs 10 billion sales. ‡ We managed through several significant challenges, and exceeded our strategic and financial goals. ‡ Our Annual Report 2010's concept focuses on Celebration of our achievements in 2010. Achieving is one of our core values means Customer- focused outcomes and world-class execution.

‡ We drive for meaningful results -demanding of ourselves and each other because our work impacts people's lives. To deliver consistently superior products and services which contribute significantly to improve the quality of life of the consumers.


‡ To be a premier healthcare company in Pakistan.


‡ The promise of our company is in the promise that our work holds for health and life.

Senior Management Team
Asif Jooma (Chief Executive Officer) Syed Anis Ahmed (Chief Financial Officer) Sadi Syed (Operations Director) Dr. Sarmad Maqbool (Marketing & Strategy Director) ‡ Dr. Farrukh Hafeez (Quality Assurance Director) ‡ ‡ ‡ ‡

Key Competitors

Abbott Products

Our Core Values
‡ Pioneering: Leading-edge science and commercialization. ‡ Achieving: Customer-focused outcomes and worldclass execution. ‡ Caring: Making a difference in people¶s lives. ‡ Enduring: Commitment and purpose.

Our Strategic Priorities
‡ Innovating for the Future (R & D). ‡ Protecting Patients & Consumers (Ensuring quality). ‡ Safeguarding the Environment.

Social Responsibilities

‡ Human Resource Development. ‡ Environment, Health and Safety.

Market Share
‡ Abbott Pakistan achieved a market share of 6.1% as per IMS (Dec 2010, 12 Months) in the pharmaceutical and nutrition market (2009 market share: 5.8%).

‡ Abbott Pakistan manufactures over 150 different pharmaceutical and general health care products for the local and export markets.

Business Process Improvement
‡ Abbott Pakistan has launched the RSO (Rationalization, Standardization, and Optimization) program through which packaging of various products is standardized to achieve operational efficiencies such as cost improvement, cycle time reduction, and better inventory management. ‡ The TPM (Total Productive Maintenance) program was launched to minimize breakdowns and reduce machine change over time to increase the productivity.

Key Financial Data
‡ Net sales for the thirteen months period registered an increase of 30% over last financial year (20% increases on 12 months comparable basis). ‡ Profit after tax for the thirteen months period was Rs 1,177 million (Financial Year 2009: Rs 609 million). Earnings per share for the thirteen months period were Rs 12.02 (Financial Year 2009: Rs 6.22 per share).

Contribution to National Exchequer
‡ Your Company has contributed Rs 1,507 million (2009: Rs 1,062 million) to the government and its agencies on account of various government levies including income tax, custom duties and sales tax etc.

Vertical Analysis

Horizontal Analysis
Profit and Loss account 2010 Net sales Cost of goods sold Gross profit Selling and distribution expenses Administrative expenses 154.36 157.03 149.33 146.29 153.5 151.5 Other operating income Other operating charges 103.3 197.25 140.64 Finance cost Profit before taxation Net taxation Profit for year 130.54 140.66 151.02 136.18 2009 118.62 131.68 94.01 114.47 115.79 72 134.44 199.48 70.81 93.38 70.76 71.43 70.47 Index analysis % 2008 100 100 100 100 100 100 100 100 100 100 100 100 100

Balance sheet 2010 Total equity Noncurrent liability Current liabilities Total equity and liabilities Noncurrent assets Current assets Total assets 109.6 114.49 127.6 114.67 121.27 111.62 114.67

Index Analysis % 2009 90.75 118.91 118.1 98.3 106.9 94.33 98.3 2008 100 100 100 100 100 100 100

Ratio Analysis
Liquidity ratios Current ratios Quick ratios 2.19 0.97 2.03 0.94 Leverage ratios Debt to equity Debt to assets 48 32.4 53 34.76 Coverage ratios Interest coverage ratios 492.27 347.92 Profitability ratios Return on investment Return on equity Net profit margin Gross profit margin 20.3 30.1 10.7 33.5 12.3 18.8 7.21 27.47 17.1 24.2 12.13 34.6 458.8 41.51 29.33 2.50 1.24

Sign up to vote on this title
UsefulNot useful

Master Your Semester with Scribd & The New York Times

Special offer: Get 4 months of Scribd and The New York Times for just $1.87 per week!

Master Your Semester with a Special Offer from Scribd & The New York Times